Bench-to-bedside review: Therapeutic management of invasive candidiasis in the intensive care unit
Open Access
- 1 January 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 14 (6), 244
- https://doi.org/10.1186/cc9239
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients*Critical Care Medicine, 2010
- Outbreak of Candida parapsilosis in a neonatal intensive care unit: a health care workers sourceEuropean Journal of Pediatrics, 2009
- Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance RegistryClinical Infectious Diseases, 2009
- Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infectionsJournal of Antimicrobial Chemotherapy, 2007
- Anidulafungin versus Fluconazole for Invasive CandidiasisNew England Journal of Medicine, 2007
- Biofilm Production by Candida Species and Inadequate Antifungal Therapy as Predictors of Mortality for Patients with CandidemiaJournal of Clinical Microbiology, 2007
- Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trialThe Lancet, 2007
- Species-Specific Differences in the Susceptibilities of Biofilms Formed by Candida Bloodstream Isolates to Echinocandin AntifungalsAntimicrobial Agents and Chemotherapy, 2007
- Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care settingEuropean Journal of Clinical Microbiology & Infectious Diseases, 2007
- Prophylaxis and treatment of invasive candidiasis in the intensive care settingEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004